no menu items
no menu items
INVESTOR RELATIONS
wide-22
presidente-6426f109d17db
Dear shareholders,
The results for the year illustrated in the document that follows tell of a year of consolidated growth, which continued in 2023 following a stable path and maintaining a steady pace in terms of sales, with a significant increase in profitability thanks to a strategy consisting of investments and increased resource efficiency, a process that will continue over time. A year in which Comer Industries confirmed its position as a leading company in the industry, while at the same time successfully continuing the work of reorganization and integration among the various souls that make up our Group.
Comer Industries has been transformed from a strategic idea to a reality: a platform of companies, each recognized and well positioned in its own market, with its own distinctive product range and its own business culture, but with the decisive added value of cooperation, of synergies of the entire Group.
Always with the same goal: to play the role of a market-leading, innovative and caring company. Focused on growth, people and environmental, social but also economic sustainability. This is the company that, with your support, we have chosen to be.
Matteo Storchi
President & CEO
Annual Report 2023
2023 Highlights
Value in millions of euro, 31st December 2023
Investors-relations_ricavi Icona
1,223.9
Consolidated Revenues
Investors-relations_ebitda adj Icona
205.0
EBITDA
Investors-relations_risultato netto adj icona
108.6
Net Income Adjusted
Investors-relations_indebitamento finanziario netto icona
94.8
Net Financial Debt
Stock performance
Theory won’t make revolutions, until it turns into practice.
Ordinary shares of Comer Industries S.p.A. (ISIN: IT0005246191) listed on the Euronext Milan, organized and managed by Borsa Italiana S.p.A.
SHAREHOLDER’S INFORMATION
Comer Industries S.p.A. shares are listed on Euronext Milan with effect from 13 July 2023. The share capital of Comer Industries amounts to Euro 18,487,338.60 and is divided into no. 28,678,090 regular entitlement shares with no par value.
SHARES
N. of Shares
% on total
Ordinary shares
12,338,001
43.02%
Ordinary shares with increased voting rights
16,340,089
56.98%
Total shares
28,678,090
100.00%

Ordinary Shares ISIN code IT0005246191

Ordinary shares with increased voting rights ISIN code IT202300000000563049

SHARES CAPITAL
Euro
N. Shares
Unit nominal value
N. Voting rights
Total shares
18,487,338.60
28,678,090
-
45,018,179
Ordinary shares
7.953.695,74
12,338,001
-
12,338,001
Ordinary shares with increased voting rights
10.533.642,86
16,340,089
-
32,680,178
SHAREHOLDERS AND VOTING RIGHTS

Comer Industries S.p.A. main shareholders; on the basis of the information available and the communications received pursuant to Art. 120 of the Consolidated Law on Finance as of 28 March 2024.
Main Shareholders
no labels
Eagles Oak srl
no labels
no labels
51,05
no labels
14,640,089
no labels
no labels
no labels
no labels
no labels
Eagles Oak srl
14,640,089
51,05 %
29,280,178
65,04 %
WPG Parent B.V.
6,843,365
23,86 %
6,843,365
15,20 %
FINREGG S.p.A. (2)
1,767,800
6,16 %
3,467,800
7,70 %
S.S. Giovanni e Paolo S.p.A.
1,566,000
5,46 %
1,566,000
3,48 %
Matteo Storchi (1)
667,186
2,33 %
667,186
1,48 %
Treasury Shares
22,195
0,08 %
22,195
0,05 %
Free-float
3,171,455
11,06 %
3,171,455
7,04 %
no labels
28,678,090
100.00 %
45,018,179
100.00 %
no labels
no labels
Contacts
Listing Agent
Alantra
Via Borgonuovo, n.16 — Milano
Specialist
EQUITA SIM S.p.A.
Via Turati, 9 – Milano
IR Contact
Alessandro Brizzi
Investor Relator Manager
Analyst Coverage
Equita
Martino De Ambroggi
Exane - BNP Paribas
Giuseppe Grimaldi
Alantra
Andrea Zampaloni
Analysts and Consensus
no labels
Equita
no labels
Martino De Ambroggi
no labels
m.deambroggi@equita.eu
no labels
September 2024
no labels
Resilient EBITDA margin and solid FCF despite AG weakness
no labels
Alantra
no labels
Andrea Zampaloni
no labels
andrea.zampaloni@alantra.com
no labels
September 2024
no labels
Operating efficiencies while market downturn deepens
no labels
Mediobanca
no labels
Andrea Balloni
no labels
Andrea.Balloni@mediobanca.com
no labels
September 2024
no labels
Resilient, though priced in. Down to Neutral
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
September 2024
no labels
Coping with a still-tough demand backdrop
no labels
Equita
no labels
Martino De Ambroggi
no labels
m.deambroggi@equita.eu
no labels
May 2024
no labels
AGRICULTURAL MARKET WEAKNESS PARTLY OFFSET BY SYNERGIES
no labels
Alantra
no labels
Andrea Zampaloni
no labels
andrea.zampaloni@alantra.com
no labels
May 2024
no labels
Robust EBITDA margin thrives in a challenging context
no labels
Mediobanca
no labels
Andrea Balloni
no labels
Andrea.Balloni@mediobanca.com
no labels
May 2024
no labels
Weak AG partially offset by cost control
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
May 2024
no labels
Solid execution in a more challenging environment
no labels
Equita
no labels
Martino De Ambroggi
no labels
m.deambroggi@equita.eu
no labels
April 2024
no labels
Triple-digit and mostly recurring FCF to finance new M&A
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
March 2024
no labels
Margins helped amid weak volumes in Q4
no labels
Alantra
no labels
Andrea Zampaloni
no labels
andrea.zampaloni@alantra.com
no labels
March 2024
no labels
Attractive FY23 FCF and DPS amid market downturn
no labels
Mediobanca
no labels
Andrea Balloni
no labels
Andrea.Balloni@mediobanca.com
no labels
March 2024
no labels
Attractive FCF at undemanding valuation
no labels
Equita
no labels
Martino De Ambroggi
no labels
m.deambroggi@equita.eu
no labels
January 2024
no labels
More synergies mitigating market volumes slowdown
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
January 2024
no labels
Momentum weighs despite undemanding valuation
no labels
Alantra
no labels
Andrea Zampaloni
no labels
andrea.zampaloni@alantra.com
no labels
October 2023
no labels
Gear up to feed the world
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
August 2023
no labels
Steady margin in progression in Q2
no labels
Mediobanca
no labels
Andrea Balloni
no labels
Andrea.Balloni@mediobanca.com
no labels
August 2023
no labels
Record margins in a normalizing market
no labels
EXANE - BNP Paribas
no labels
Giuseppe Grimaldi
no labels
Giuseppe.Grimaldi@exanebnpparibas.com
no labels
May 2023
no labels
AG business in full swing
no labels
Mediobanca
no labels
Andrea Balloni
no labels
Andrea.Balloni@mediobanca.com
no labels
March 2023
no labels
Solid FCF leaves room for further deals
no labels
no labels
no labels
no labels
no labels
Equita
Martino De Ambroggi
m.deambroggi@equita.eu
September 2024
Resilient EBITDA margin and solid FCF despite AG weakness
Alantra
Andrea Zampaloni
andrea.zampaloni@alantra.com
September 2024
Operating efficiencies while market downturn deepens
Mediobanca
Andrea Balloni
Andrea.Balloni@mediobanca.com
September 2024
Resilient, though priced in. Down to Neutral
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
September 2024
Coping with a still-tough demand backdrop
Equita
Martino De Ambroggi
m.deambroggi@equita.eu
May 2024
AGRICULTURAL MARKET WEAKNESS PARTLY OFFSET BY SYNERGIES
Alantra
Andrea Zampaloni
andrea.zampaloni@alantra.com
May 2024
Robust EBITDA margin thrives in a challenging context
Mediobanca
Andrea Balloni
Andrea.Balloni@mediobanca.com
May 2024
Weak AG partially offset by cost control
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
May 2024
Solid execution in a more challenging environment
Equita
Martino De Ambroggi
m.deambroggi@equita.eu
April 2024
Triple-digit and mostly recurring FCF to finance new M&A
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
March 2024
Margins helped amid weak volumes in Q4
Alantra
Andrea Zampaloni
andrea.zampaloni@alantra.com
March 2024
Attractive FY23 FCF and DPS amid market downturn
Mediobanca
Andrea Balloni
Andrea.Balloni@mediobanca.com
March 2024
Attractive FCF at undemanding valuation
Equita
Martino De Ambroggi
m.deambroggi@equita.eu
January 2024
More synergies mitigating market volumes slowdown
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
January 2024
Momentum weighs despite undemanding valuation
Alantra
Andrea Zampaloni
andrea.zampaloni@alantra.com
October 2023
Gear up to feed the world
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
August 2023
Steady margin in progression in Q2
Mediobanca
Andrea Balloni
Andrea.Balloni@mediobanca.com
August 2023
Record margins in a normalizing market
EXANE - BNP Paribas
Giuseppe Grimaldi
Giuseppe.Grimaldi@exanebnpparibas.com
May 2023
AG business in full swing
Mediobanca
Andrea Balloni
Andrea.Balloni@mediobanca.com
March 2023
Solid FCF leaves room for further deals
no labels

no labels

no labels